BENJAMIN D MARGOLIS

Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease BANNOCKBURN, IL NPI 1174600514

General Payments — all program years on this page

$3,148.97

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 47
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,229.35 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,218.4917
Education $10.861

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $493.247
2019 $264.106
2020 $25.712
2021 $215.192
2022 $384.032
2023 $537.3510
2024 $1,229.3518

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077583114 Ethicon Inc. $56.88 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104211683 AstraZeneca Pharmaceuticals LP $10.86 11/12/2024 Education Undisputed 01/23/2026 View at CMS
1104361135 AstraZeneca Pharmaceuticals LP $121.83 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104426749 AstraZeneca Pharmaceuticals LP $14.52 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104760812 AstraZeneca Pharmaceuticals LP $120.60 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105494599 AstraZeneca Pharmaceuticals LP $121.23 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105532052 AstraZeneca Pharmaceuticals LP $127.31 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105574678 AstraZeneca Pharmaceuticals LP $15.42 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114108322 Regeneron Healthcare Solutions, Inc. $124.26 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117903026 Boehringer Ingelheim Pharmaceuticals, Inc. $31.75 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117903028 Boehringer Ingelheim Pharmaceuticals, Inc. $115.75 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140204799 Resmed Corp $23.00 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146852383 Philips North America LLC $18.37 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146852385 Philips North America LLC $14.01 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146852387 Philips North America LLC $33.34 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147573451 3B Medical, Inc. $39.02 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149463292 United Therapeutics Corporation $120.60 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149476574 United Therapeutics Corporation $120.60 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.